Patents by Inventor Lionel G. King

Lionel G. King has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030143726
    Abstract: The present invention provides biosensors which include or are fabricated using optically sensitive moieties. The use of optically sensitive moieties provides advantages in the synthesis of the biosensors. Further the inclusion of optically sensitive moieties in the biosensor membrane provides an increase in the sensitivity of detection.
    Type: Application
    Filed: February 5, 2003
    Publication date: July 31, 2003
    Applicant: Australian Membrane and Biotechnology Research Institute
    Inventors: Peter D. Osman, Christopher J. Burns, Alistair S. Martin, Lionel G. King
  • Patent number: 6537441
    Abstract: The present invention provides biosensors which include or are fabricated using optically sensitive moieties. The use of optically sensitive moieties provides advantages in the synthesis of the biosensors. Further the inclusion of optically sensitive moieties in the biosensor membrane provides an increase in the sensitivity of detection.
    Type: Grant
    Filed: July 28, 2000
    Date of Patent: March 25, 2003
    Assignees: Australian Membrane and Biotechnology Research, The University of Sydney
    Inventors: Peter D. Osman, Christopher J. Burns, Alistair S. Martin, Lionel G. King
  • Patent number: 5874316
    Abstract: The present invention provides a membrane the conductivity of which is dependent on the presence or absence of an analyte. The membrane comprises a closely packed array of self-assembling amphiphilic molecules and two ionophore components. A receptor molecule reactive with the analyte is provided on one of the ionophore components. The binding of the analyte to the receptor molecule causes a change in the relationship between the ionophore components such that the flow of ion across the membrane is prevented or allowed. The ionophore components are preferably selected from the group consisting of amphotericin B, gramicidin A monomers and combinations thereof, with gramicidin A monomers being particularly preferred. The present invention also provides a membrane including receptors directed against the Fc region of antibodies. These receptors are preferably derived from polyclonal antibodies.
    Type: Grant
    Filed: October 30, 1996
    Date of Patent: February 23, 1999
    Assignee: Australian Membrane Biotechnology Research Institute
    Inventors: Bruce A. Cornell, Vijoleta L. B. Braach-Maksvytis, Ronald J. Pace, Lionel G. King, Burkhard Raguse, Peter D. J. Osman
  • Patent number: 5591647
    Abstract: Membrane for use in the detection of an analyte having a closely packed array of self-assembling amphiphilic molecules and a plurality of ionophores. First and second ligands are attached to an end of the ionophores adjacent the surface of the membrane. The membrane is such that the binding of the first ligand to its specific binding partner prevents the flow of ions across the membrane via the ionophores. In addition, the binding of the second ligand to its specific binding partner prevents the binding of the first ligand to its specific binding partner.
    Type: Grant
    Filed: May 17, 1995
    Date of Patent: January 7, 1997
    Assignees: Australian Membrane and Biotechnology Research Institute, The University of Sydney
    Inventor: Lionel G. King
  • Patent number: 5443955
    Abstract: The present invention provides a membrane the conductivity of which is dependent on the presence or absence of an analyte. The membrane comprises a closely packed array of self-assembling amphiphilic molecules and two ionophore components. A receptor molecule reactive with the analyte is provided on one of the ionophore components. The binding of the analyte to the receptor molecule causes a change in the relationship between the ionophore components such that the flow of ion across the membrane is prevented or allowed. The ionophore components are preferably selected from the group consisting of amphotericin B, gramicidin A monomers and combinations thereof, with gramicidin A monomers being particularly preferred. The present invention also provides a membrane including receptors directed against the Fc region of antibodies. These receptors are preferably derived from polyclonal antibodies.
    Type: Grant
    Filed: July 3, 1991
    Date of Patent: August 22, 1995
    Assignee: Australian Membrane and Biotechnology Research Institute
    Inventors: Bruce A. Cornell, Vijoleta L. B. Braach-Maksvytis, Ronald J. Pace, Lionel G. King, Burkhard Raguse, Claire R. Baxter, Ruth M. Hall, Carol A. Morris, Peter D. J. Osman
  • Patent number: 5401378
    Abstract: The present invention relates to electrode membrane combinations for use in biosensors. The membrane is attached to the electrode by means of a linker molecule in a manner such that a hydrophilic space is provided between the membrane and the electrode. The linker molecule comprises within the same molecule a hydrophobic region which constitutes at least a proportion of the amphiphilic molecules making up the membrane or is attached to or is embedded in the membrane, an attachment region attached to the electrode and a hydrophilic region intermediate said hydrophobic and attachment regions. The hydrophilic region spans the space between the membrane and the electrode.
    Type: Grant
    Filed: September 21, 1993
    Date of Patent: March 28, 1995
    Assignee: Australian Membrane & Biotechnology Research Institute
    Inventors: Lionel G. King, Burkhard Raguse, Bruce A. Cornell, Ronald J. Pace
  • Patent number: 5234566
    Abstract: The present invention provides a biosensor comprising at least one lipid membrane, each membrane including at least one gated ion channel. The membranes comprise a closely packed array of self-assembly amphophilic molecules and the gated ion channel has a conductance which is dependent upon an electric field applied across the membrane. The biosensor of the present invention may comprise a plurality of discrete membranes each including at least one gated ion channel. The conductance of each of the membranes is measurable independently of the conductance of the other membranes.
    Type: Grant
    Filed: April 18, 1991
    Date of Patent: August 10, 1993
    Assignee: Australian Membrane and Biotechnology Research Institute Ltd.
    Inventors: Peter D. J. Osman, Bruce A. Cornell, Burkhard Raguse, Lionel G. King